Asthma in Patients With Japanese Cedar Pollinosis

被引:0
|
作者
Tanaka, Akihiko [1 ]
Minoguchi, Kenji [2 ]
Pawankar, Ruby [3 ]
Adachi, Mitsuru [1 ]
机构
[1] Showa Univ, Div Allergy & Resp Med, Dept Internal Med, Tokyo, Japan
[2] Sumiregaoka Clin, Yokohama, Kanagawa, Japan
[3] Nippon Med Sch, Tokyo, Japan
来源
关键词
Japanese cedar pollinosis; asthma; allergic rhinitis;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea, nasal obstruction, nasal itching, and itching of the eyes. Previous reports indicate that the prevalence of Japanese cedar pollinosis among Japanese was 26.5%. According to a more recent questionnaire-based survey, the prevalence of Japanese cedar pollinosis in patients with adult asthma might be up to 30% to 50%, suggesting higher rates than that previously reported. Moreover, 30% to 60% of adult asthmatic patients with concomitant pollinosis have exacer-bations of their asthma symptoms during the Japanese cedar pollen season. These findings suggest that concomitant Japanese cedar pollinosis may be an aggravating factor in patients with asthma. As with other pollens, such as grass and birch, Japanese cedar pollen was shown to be a trigger factor for worsening asthma. In clinical practice, a number of Japanese patients with asthma are mono-sensitized to Japanese cedar pollen but not to other antigens. Further studies are needed to elucidate the mechanisms of Japanese cedar pollen in inducing and in exacerbating asthma. The presence of concomitant AR is often associated with the difficulty in asthma control. However, there has been a controversy whether treating concomitant AR by intranasal corticosteroid would produce better asthma-related outcomes in patients with asthma and AR. The effect of treating concomitant cedar pollinosis by intranasal corticosteroids on asthma control in patients with asthma and cedar pollinosis also remains unknown. Certain systemic treatments, such as leukotriene receptor antagonist and anti-IgE monoclonal antibody, are supposed to reduce the symptoms of both asthma and AR in patients with asthma and concomitant AR. In conclusion, Japanese cedar pollinosis is often associated with exacerbations of asthma. Further investigations are expected to elucidate the precise impact and mechanisms of Japanese cedar pollinosis in asthma.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Investigation of the sensitization rate for gibberellin-regulated protein in patients with Japanese cedar pollinosis
    Mori, Yuji
    Okazaki, Fumiko
    Momma, Keiko
    Narita, Hiroshi
    Kondo, Yasuto
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2022, 50 (02) : 89 - 92
  • [42] An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients
    Imanaka, Takahiro
    Sato, Izumi
    Kawasaki, Yohei
    Kanazawa, Yuji
    Kawakami, Koji
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2019, 9 (06) : 615 - 623
  • [43] Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis
    Gotoh, Minoru
    Okubo, Kimihiro
    Hashiguchi, Kazuhiro
    Wakabayashi, Ken-ichiro
    Kanzaki, Sho
    Tanaka, Nobuaki
    Fujioka, Masato
    Kawashima, Kayoko
    Suematsu, Kiyochika
    Sasaki, Koichi
    Iwasaki, Manabu
    Yamamotoya, Hajime
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (06) : 459 - 466
  • [44] The efficacy of prophylactic ebastine administration for the treatment of Japanese cedar pollinosis
    Ishimitsu, R
    Kataoka, S
    Sano, K
    Iwamoto, J
    Kawauchi, H
    E.R.S. & I.S.I.A.N. MEETING '98, 1998, : 149 - 153
  • [45] Effects of sublingual immunotherapy on a murine model of Japanese cedar pollinosis
    Azuma, Miyuki
    Zhang, Chenyang
    Yanagisawa, Shohei
    Tomoda, Taketo
    Kang, Siwen
    Ohno, Tatsukuni
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [46] Japanese Cedar (Cryptomeria japonica) Pollinosis in Jeju, Korea: Is It Increasing?
    Lee, Jaechun
    Lee, Keun Hwa
    Lee, Hye-Sook
    Hong, Sung-Chul
    Kim, Jeong Hong
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2015, 7 (03) : 295 - 300
  • [47] A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis
    Horiguchi, Shigetoshi
    Okamoto, Yoshitaka
    Yonekura, Syuji
    Okawa, Toru
    Yamamoto, Heizaburou
    Kunii, Naoki
    Sakurai, Daijyu
    Fujimura, Takashi
    Nakazawa, Kazuyoshi
    Yasueda, Hiroshi
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2008, 146 (01) : 76 - 84
  • [48] Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis
    Fujii, Tatsuya
    Kitamura, Yoshiaki
    Kamimura, Seiichiro
    Takeda, Noriaki
    JOURNAL OF MEDICAL INVESTIGATION, 2022, 69 (1-2): : 97 - 100
  • [49] Involvement of Staphylococcus aureus and Moraxella catarrhalis in Japanese cedar pollinosis
    Otsuka, Hirokuni
    Takanashi, Ikuo
    Tokunou, Shunsuke
    Endo, Sadao
    Okubo, Kimihiro
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2016, 30 (02) : 99 - 106
  • [50] IMPACT OF OMALIZUMAB ON PAID AND UNPAID WORK PRODUCTIVITY AMONG SEVERE JAPANESE CEDAR POLLINOSIS PATIENTS
    Igarashi, A.
    Hashiguchi, K.
    Mueller, M.
    Kappel, M.
    Funakubo, M.
    Sharma, H.
    Oka, H.
    Okano, M.
    VALUE IN HEALTH, 2020, 23 : S723 - S723